title: Effects of metalloprotease anthrax lethal factor on its peptide-based inhibitor R9LF-1.
abstract: The metalloprotease lethal factor (LF) from Bacillus anthracis plays a vital role in anthrax toxin action, and thus becomes a target for anti-anthrax therapy. Following the guidelines based on existing metalloprotease inhibitors, we designed a 'first-generation' LF inhibitor R9LF-1. This inhibitor was shown to be very stable by itself in a wide range of pH and temperature and able to inhibit LF activity in vitro. However, as we reported previously in the presence of LF, this inhibitor was degraded to a small molecular weight species, resulting in a significantly decreased ability to protect MAPKK from cleavage by LF as well as to protect murine macrophages from lethal toxin. In order to elucidate this unusual phenomenon to build solid basis for high-efficiency LF inhibitor development, we performed extensive research to study the effect of LF on its peptide-based inhibitor. Effects of temperature and incubation period of time on generation of the smaller peptide (short version R9LF-1) by LF as well as its catalytic domain were analyzed. We found that LF degraded R9LF-1 with maximum efficiency in the pH range of 7.0-8.5, which correlates well with the range of LF enzymatic activity with its native substrate. The degradation showed a deviation from normal hyperbolic kinetics but a similarity to the kinetics profile of an enzyme-catalyzed reaction with positive cooperativity. The short version R9LF-1 had decreased inhibitory activity toward LF; surprisingly, BIAcore results suggested a better affinity for its binding to LF. In addition, R9LF-1 was not hydrolyzed by other common proteases, such as chymotrypsin and pepsin, suggesting hydrolysis of the bond between amino acid and hydroxamate groups is unique to LF. This study calls for caution when designing peptide-based LF inhibitors and when interpreting effects of these types of inhibitors.
authors.affiliation: Jining Medical University, Jining, 272067, Shandong, People's Republic of China.
authors.forename: Qingsheng
authors.initials: Q
authors.lastname: Kong
authors.forename: Yuezhang
authors.initials: Y
authors.lastname: Song
authors.forename: Minlei
authors.initials: M
authors.lastname: Mu
authors.forename: Xiaolin
authors.initials: X
authors.lastname: Han
authors.forename: Chuanping
authors.initials: C
authors.lastname: Si
authors.forename: Feng
authors.initials: F
authors.lastname: Li
mesh_terms: D000942:Antigens, Bacterial / Q000737:chemistry*; D001427:Bacterial Toxins / Q000737:chemistry*; D002918:Chymotrypsin / Q000737:chemistry; D007700:Kinetics; D045726:Metalloproteases / Q000737:chemistry*; D009842:Oligopeptides / Q000737:chemistry*; D011480:Protease Inhibitors / Q000737:chemistry*; D011485:Protein Binding; D059748:Proteolysis
chemical_list: D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D009842:Oligopeptides; D011480:Protease Inhibitors; C030325:anthrax toxin; C000606949:peptide-based inhibitor R9LF-1; D045726:Metalloproteases; D002918:Chymotrypsin